![](/img/cover-not-exists.png)
614TiPPhase II study of Ccr-based dose-control of S-1 in the first-line chemotherapy of S-1/oxaliplatin (SOX) + bevacizumab regimen for advanced colorectal cancer
Manaka, D., Nishitai, R., Konishi, S., Ohta, T., Hattori, T., Ann, H., Kawaguchi, K., Nishikawa, Y., Kudo, R., Hamasu, S.Volume:
28
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx393.139
Date:
September, 2017
File:
PDF, 72 KB
2017